US HB1834 | 2017-2018 | 115th Congress
Status
Sponsorship: Bipartisan Bill
Status: Introduced on March 30 2017 - 25% progression, died in committee
Action: 2017-04-12 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on March 30 2017 - 25% progression, died in committee
Action: 2017-04-12 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Cancer Care Payment Reform Act of 2017 This bill amends title XVIII (Medicare) of the Social Security Act to establish the Oncology Medical Home Demonstration Project, through which the Centers for Medicare & Medicaid Services (CMS) shall make special payments to participating oncology practices that coordinate patient care and meet other specified requirements. During the first two years of the project, CMS shall pay a care coordination management fee to each such practice. After the third, fourth, and fifth years of the project, CMS shall pay a performance incentive payment to each participating practice that meets or exceeds performance standards developed by CMS. CMS shall assess the performance of each participating oncology practice annually. Performance standards shall address: (1) specified measures related to patient care, resource utilization, survivorship, and end-of-life care; and (2) the patient experience of care, as reflected in surveys submitted by each practice. CMS shall also assess the extent to which a practice has used breakthrough or other best-in-class therapies. To the extent practicable, CMS shall select practices of varying sizes and geographic areas for participation.
Title
Cancer Care Payment Reform Act of 2017
Sponsors
| Rep. Cathy McMorris Rodgers [R-WA] | Rep. Terri Sewell [D-AL] |
History
| Date | Chamber | Action |
|---|---|---|
| 2017-04-12 | House | Referred to the Subcommittee on Health. |
| 2017-03-31 | House | Referred to the Subcommittee on Health. |
| 2017-03-30 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
| 2017-03-30 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
| 2017-03-30 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
| 2017-03-30 | House | Introduced in House |
Same As/Similar To
SB463 (Same As) 2017-02-28 - Read twice and referred to the Committee on Finance. (text of measure as introduced: CR S1502-1504)
Subjects
Cancer
Cardiovascular and respiratory health
Digestive and metabolic diseases
Drug therapy
Emergency medical services and trauma care
Health
Health care quality
Health information and medical records
Home and outpatient care
Long-term, rehabilitative, and terminal care
Medicare
Performance measurement
Women's health
Cardiovascular and respiratory health
Digestive and metabolic diseases
Drug therapy
Emergency medical services and trauma care
Health
Health care quality
Health information and medical records
Home and outpatient care
Long-term, rehabilitative, and terminal care
Medicare
Performance measurement
Women's health
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/115th-congress/house-bill/1834/all-info |
| Text | https://www.congress.gov/115/bills/hr1834/BILLS-115hr1834ih.pdf |
